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INTRODUCTION 
One of the hormones involved in human development, 
especially the development of the nervous system of the 
thyroid hormones.
1,2
 So early diagnosis and treatment of 
hypothyroidism can prevent mental retardation in 
congenital defects of these hormones.
3
 
For the prevention and treatment of neurological 
disorders and mental retardation in hypothyroidism over 
the last decade, many efforts have been done in low 
developed or underdeveloped countries.
4,5
 
Before the onset of the screening system (until 1970), 
more than a third of children with hypothyroidism were 
not diagnosed for a long time and in the years after the 
infancy they experienced severe mental and nervous 
disorders and at this step was no possibility of treatment 
and prevention of the disease so that the delay in 
diagnosis and treating of hypothyroidism for 5 to 6 
months cause to reduce the level of intelligence of 
individuals below 70 (IQ<).
6,7
 
In the province of Ardabil, the program for the screening 
of congenital thyroid disease began in late 2006 at the 
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same time as a national screening program. Before the 
onset of the neonatal screening program, the incidence of 
congenital hypothyroidism, which was diagnosed with 
clinical manifestations, was between 1:7000 and 1:5000 
with the onset of neonatal screening, the incidence ranged 
reached to 1:3000 to 1:4000 live births. By increasing the 
experience of health systems and performing a global 
screening program, it seems that hypothyroidism to be 
different based on geographic areas and more than this 
amount.
8
 
In a report from France based on a neonatal screening 
system over the 20 year, the prevalence of congenital 
hypothyroidism was 1:1000 live birth and in a report 
from Greece over the 11 years of screening, the 
prevalence was much higher and was about 1:800 
birth.
9,10
  
According to reports, in the United States neonates, the 
incidence of congenital hypothyroidism has risen from 
1:4094 in 1987 to 1:2372 live births in 2002 which the 
reason for this increase unknown but researchers consider 
the progress of laboratory assessment and evaluation 
tools as one of the reasons for the accurate determination 
of thyroid hormones levels which has increased the 
prevalence in this interval.
11
  
By increasing sensitivity and validity of TSH level 
measurement methods in many screening systems in the 
world and in the United States, measuring the level of the 
T4 hormone has changed to TSH level measurements. By 
pull down the cut off level of TSH many infants with 
mild congenital hyperthyroidism has been diagnosed. In 
addition, TSH level changes in many geographic areas 
and races of population has not difference and is suitable 
for screening. In many US screening systems for Asian 
migrant population a high prevalence of congenital 
hypothyroidism has been reported but among African 
Americans this prevalence has been very low and in 
totally, the prevalence of hypothyroidism among white 
populations is reported more than blacks. In the screening 
program in New York during the years 2000 to 2003, the 
incidence of congenital hypothyroidism was generally 
1:1613 and among boys was 1:1763 and girls were 
1:1651. In cases with the birth weight between 1500 g 
and 2500 g, the prevalence was higher and reached to 
1:851 live births and under 1500 gr the birth weight, the 
prevalence was 1:1396.
11
 The aim of this study was to 
evaluate the results of permanent and transient congenital 
hypothyroidism screening in Ardabil province. 
METHODS 
This descriptive study was conducted in health centers of 
Ardabil province on infants born during 2007 to 2013 
(158624 live birth) that out of them 5600 cases were 
recalled for evaluation again. 
According to the country congenital hypothyroidism 
screening program is performed using a neonatal 
hepatocellular blood sample that occurs 3 to 5 days after 
birth and TSH is measured by ELIZA and is considered 
normal if TSH is less than 5 mU/L. If the result of the 
TSH was between 5 and 9.9 mU/L, in age 4 weeks, TSH, 
T3RU and T4 were checked for infants by getting 
intravenous blood sample of them. 
If the result of the TSH test was between 10 and 9.9 
mU/L, a blood sample is given at 2 to 3 weeks and if the 
primary titer is greater than or equal to 20 mU/L then 
intravenous testing is immediately checked and if the 
initial titer is greater than or equal to 20 mU/L then 
venous testing is immediately checked and treatment with 
Levothyroxine is prescribed. If the venous T4 test is less 
than 6.5 μg / dL and TSH is greater than 20 mU/L, a 
diagnosis of hypothyroidism is given and the treatment 
begins or continues if it has already begun. 
In this study, cases with TSH equal 5 mU/L or more were 
considered as Recall samples. The cases of 
hypothyroidism were diagnosed and after 3 years of 
hypothyroidism and were considered as congenital 
hypothyroidism and its frequency in the total screened 
population was calculated. Finally at the end of the 3 year 
or for any reason prior to thyroxine administration and 
had normal thyroid function were considered congenital 
hypothyroidism. The collected data were analyzed by 
SPSS v16 using statistical methods including Chi-square 
and T-test and descriptive statistics methods in the form 
of table and diagram. In all tests a significant level was 
set as p<0.05. 
RESULTS 
Of all recall infants, 220 (3.9%) neonates based on 
screening results and TSH amount were suffered to 
congenital hypothyroidism. 
The incidence of congenital hypothyroidism (transient 
and permanent) in Ardabil province was 1 patient in 916 
live births. Of the total number of patients 180 cases 
(81.8%) of transient hypothyroidism and 40 cases 
(18.2%) of permanent hypothyroidism were followed up 
for 1 year. Of these 180 infants, 102 newborns (56.7%) 
were female. 
Table 1: Socio-demographic data of patients. 
Variables n % 
Sex  
Girl  102 56.7 
Boy  78 43.3 
Family history (+) 117 60.9 
Mean±SD 
Weight  3.2±0.5 
Height  49±3.1 
TSH in first time 29.7±26.7 
TSH in second time 30.6±28 
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Table 2: Growth indexes of infants with congenital hypothyroidism. 
Variables Birth time 1 month 4 months 6 months 9 months 12 months 
Round the head (cm) 35.5±0.8 37.8±0.54 42.1±0.7 43.8±0.74 45.7±0.74 47±0.9 
Weight (kg) 3328±3.25 4467±3.48 7016±3.53 8118±3.57 9285±3 9646±2 
Height (cm)  50±1.4 53.7±1.3 62.9±1.2 67.1±1.5 71.6±1.2 75.1±1.3 
Weight to height ratio (%) 42.1±28.1 51.6±28.7 63.6±19.4 70.3±17.4 74±12.3 76.5±13.6 
Table 3: Weight, height, round of the head and weight to height ratio in infants with congenital hypothyroidism by 
sex. 
Variables Sex Birth time 1 month 4 months 6 months 9 months 12 months 
Round the 
head (cm) 
Girl  43.3 45.2 48.6 58.2 59.8 64.4 
Boy 55.6 61.9 67.2 74.3 80.1 80.3 
P value 0.11 0.005 0.001 0.001 0.001 0.001 
Weight (kg) 
Girl  40.6 31 31.4 34.8 37.8 41.5 
Boy 70.1 59.1 64.5 69.7 69.8 65.6 
P value 0.001 0.001 0.001 0.001 0.001 0.001 
Height (cm)  
Girl  67.3 63.8 65.9 72.5 71.6 76.7 
Boy 83 81.8 77 77.8 81.1 83.5 
P value 0.002 0.001 0.055 0.22 0.092 0.2 
Weight to 
height ratio 
(%) 
Girl  49.5 59 65.3 73.4 69.7 72.1 
Boy 35.5 44.9 62.1 67.5 77.8 80.4 
P value 0.12 0.12 0.6 0.29 0.038 0.053 
 
The average height and weight of newborns with 
hypothyroidism at birth were 49.01±3.05 and 
3.192±0.473 respectively. The average of the first TSH 
among 180 neonates with hypothyroidism was 29.7±26.7 
μIU/ml and its level was 30.6±28 μIU/ml in the second 
time. The median of TSH in these patients was at the first 
and second times of 16 and 21. Of the 081 infants, 117 
(60.9%) had positive familial history (Table 1). The 
incidence of transient and persistent hypothyroidism in 
this study was 1 to 916 and the definitive permanent 
hypothyroidism prevalence was 1 to 4000. Of the 40 
infants with permanent hypothyroidism, 21 (52.5%) were 
female and the mean age of treatment in these patients 
was 18.45±6.22 days. 16 (40%) infants were born from 
non-family marriage. 13 newborn (32.5%) had a positive 
familial history of thyroid disease. In newborns with 
permanent hypothyroidism the average of TSH levels in 
the first and second times was 37.15 and 31.56 μIU/ml, 
respectively. The average of T4 and T3RU levels in these 
infants was 16.04 μg/dl and 4.74 mg/dl, respectively. In 
these infants, height increase, weight to height ratio, 
Round the head (both centimeters and percentile) were 
statistically significant during the studied times (at birth 
time, 1,4,6,9 and 12 months late) (Table 2). 
Weight, height, round the head and percentile of weight 
to height by sex were also investigated at different times. 
The results showed that the percentile of weight in the 
boys significantly was more than girls at times 1, 4, 6, 9 
and 12 months of age. The percentile of weight in boys in 
all cases was significantly higher than girls. A percentile 
around the head in boys at birth time and one month late 
was significantly more than girls. In the study of 
percentiles of weight to height in boys, only 9 and 12 
months were more than girls and in other cases it was less 
than girls and significant difference was observed at 9 
month of age. There was no significant difference 
between the sex and level of TSH. The level of T4 at 
birth time in boys with 4.91 was significantly lower than 
girls with 10.26 (p=0.044). There was no significant 
difference at the level of T3RU between girls and boys 
(Table 3). 
DISCUSSION 
In this study, the recall rate of infants was 5600 infants 
and the hypothyroidism (permanent and transient) was 
180 infants (0.03%, 1:916 live births) and permanent 
hypothyroidism was 0.7% (1:4000 live births). 
In studies conducted elsewhere, the prevalence of 
hypothyroidism varied from 0.7 per 1,000 live births to 
7.1 per 1,000 and in the present study, the prevalence of 
hypothyroidism with 39 per 1000 was higher than other 
studies.
12-16
 
According to research in the world, the prevalence of 
congenital hypothyroidism varied from 0.14 per 1,000 
live births in Japan to 14.7 per 1,000 infants in Nigeria 
which lower than the present study.
7,17,18
 
The causes of the different prevalence of the disease in 
different parts of the world can be due to the different 
contraceptive criteria for the diagnosis of 
hypothyroidism, use of T4 or TSH to screen, iodine 
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deficiency in some parts of the world, the percentage of 
different marriages and ethnic and racial differences.19-25 
In this study, the rate of recall was 5600 cases or 35 cases 
per 1000 (3.5%) infants. In the Siami’s study (25), the 
recall rate was 6.1%. In other countries, the sampling rate 
of the heel was 0.3-0.1% and in the umbilical cord 
sampling was 0.16-1.05%.15,28 
The rates of recall in other countries are usually different 
with the usual screening methods between 3-5 days after 
birth from 0.16% in the Philippines and 2.3% in Turkey 
to 3.3% in Estonia.
23,26,27
 One of the reason for the high 
recall rate in this study is that due to the importance of 
illness and impose high economic cost, the TSH>5 was 
considered as the basis for recall that in other studies, the 
usual limit for screening of hypothyroidism is TSH>10 
mu/L.
16
  
In this study, 56.7% of infants with permanent and 
transient hypothyroidism and 52.5% of infants with 
permanent hypothyroidism were girl. In terms of low 
prevalence of hypothyroidism in Saudi Arabia female to 
male ratio 1.8 to 1, in Estonia 4 to 1 and in China 3 to 2, 
and in other studies in Mazandaran, as well as study by 
Siami and colleagues, this ratio was almost equal. 
15,24,25,27
 
Among newborns with permanent and transient 
hyperthyroidism 39.1% and 32.5% of newborns with 
permanent hyperthyroidism had a positive history of 
disease. The relative familial relation in Ordoukhani 
study was 68.2%, which was higher than the present 
study and diet and environmental factors are involved in 
this, which requires more studies in the future. 13 Based 
on results of more studies, early detection and therapy 
with thyroxin potentially prevent developmental 
disorders of the nervous system.28 In few studies, early 
treatment has also been effective in improving the 
intelligence of these patients but in two other studies this 
communication was not significant.
29,30  
In this study the average birth weight of babies was 3.328 
kg. After assessing the percentile weight of newborns, it 
was observed that with increasing age, the weight 
percentile of newborns also increased and all babies at all 
stages of their monitoring were above the percentile of 
3%. However in a study conducted in New York in 2000-
2003, the highest number of neonates with a 
hypothyroidism weighing less than 2500 gr and at a 
weight above 2500 gr the prevalence of hypothyroidism 
had been low.
30
 Several studies have concluded that with 
the onset of timely treatment, the weight of neonates is 
close to normal.31 In a study on 2341 children with 
congenital hypothyroidism in Japan in 2007, the growth 
of these children in case of onset of treatment between 
standard deviation -2 and +2 was reported.  
After review the height of the infants, it was observed 
that with increasing age at first one month of age, the 
percentile age decreased and then the percentile height 
increased which this increase has raised between 9-12 
months. In the Feyzi and et al study, the height of 
children at age of 5 reached to normal values. Although 
some studies did not observe any differences in the 
growth rates of children in the affected population, some 
reported natural growth at age 3 and others at age 6.31-33 
Moschini and et al reported normal growth height at the 
age of 6 in children with an average age of treatment 
beginning at 33 days.
34
 
CONCLUSION 
Based on the evidence from this study, congenital 
hypothyroidism has a high prevalence in Ardabil. The 
average starting age of treatment after diagnosis and its 
distance from the birth is at an acceptable distance. 
Comparing the results of this study with other studies in 
other countries suggests the proper efficacy of congenital 
hypothyroidism screening in Ardabil's health system. 
In future studies, consideration should be given to other 
environmental factors especially during pregnancy which 
affect the functioning of the mother's thyroid and 
consequently the baby. Because of positive familial 
history in one quarter of patients, we can noted the role of 
other environmental factors in addition to genetic factors 
in the high incidence of hypothyroidism in the Ardabil 
area. Increasing the length of follow-up in infants with 
hypothyroidism until adolescence can better determine 
the quality of treatment in the neonatal period by 
assessing their IQ and their educational performance and 
suggesting future studies in this regard.  
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